Marina V. Komarova

Marina V. Komarova

Auto-generated profile, based on publicly available information

Marina V. Komarova

Samara National Research University

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2017 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
EME.A. Morozova
E.A. Morozova
NANatalya Anufrieva
Natalya Anufrieva
DDD.ZH. Davydov
D.ZH. Davydov
MKM.V. Komarova
M.V. Komarova
IDI.N. Dyakov
I.N. Dyakov
VPVadim Pokrovsky
Vadim Pokrovsky

13 September 2019 in Amino Acids
Verified
Journal Article
Closed access
PDF file
SSSergey P. Syatkin
Sergey P. Syatkin
ENEkaterina Владиславовна Neborak
Ekaterina Владиславовна Neborak
Andrei KhlebnikovAndrei Khlebnikov
Andrei Khlebnikov
MKMarina V. Komarova
Marina V. Komarova
NSNatalia A. Shevkun
Natalia A. Shevkun
EAEnzo Agostinelli
Enzo Agostinelli

27 March 2019 in Hygiene and sanitation
Verified
Journal Article
Open access
IKIrina G. Kretova
Irina G. Kretova
OVO. A. Vedyasova
O. A. Vedyasova
MKM. V. Komarova
M. V. Komarova
OSO. I. Shiryaeva
O. I. Shiryaeva
Introduction. Currently, there is a deterioration trend in the health of the younger generation, in particular, an increasing number of persons with functional disorders of the cardiovascular system. Regarding this it is important to develop an comprehensive approach to the study of the circulatory indices in the young age with informative clinical diagnostic techniques and new ways to analyze the data. Material and methods. Heart rate variability (HRV) indices in 200 students at rest and during exercise were studied. For a more complete assessment of the functional reserves of cardiovascular system after the load the index of the normal heart rhythm restoration (SDNN) was calculated. Moreover, we built logistic models and curves of the operating characteristics. Results. At rest, no significant differences in indices of both HRV and autonomic regulation of heart rate have been identified between boys and girls aged of 16-18 years. Students of the different gender, aged of 19-22 years showed significant differences in spectral parameters of HRV, there was noted the dominance of the sympathetic component of heart rate regulation in boys and parasympathetic - in girls. In terms of physical activity in undergraduate students there is observed mainly the activation of vagal influences on the heart, in senior students the vegetative balance shifted to the direction of the increased activity of mechanisms of the sympathetic regulation. The revealed decrease of NHRR reflects the low level of the reserve capacity of the cardiovascular system in 41% out of observed students. Part of students with an increased probability of the reduction of functional cardiac disorders accounted for 42% of boys and 39% of girls among students aged 16-18 years and 36% of boys and 44% of girls among students aged of 19-22 years. Conclusion. There is a change in the nature of autonomous regulation of heart rate in students of different gender and ages from 16-18 to 19-22 years. The optimal cardiac response to stress test is observed at low baseline values of heart rate and the prevalence of the parasympathetic part of the autonomic regulation of the heart rate at rest. To assess the functional reserve of the cardiovascular system in HRV indices we recommend the calculation of NHRR and the analysis of the SDNN coefficient for the effective prediction of heart rate recovery rate after exercise testing.

25 December 2018 in Kardiologiia
Verified
Journal Article
Open access
PDF file
ELE. S. Luboyatnikova
E. S. Luboyatnikova
AKA. R. Kiselev
A. R. Kiselev
MKM. V. Komarova
M. V. Komarova
VRV. A. Rodionova
V. A. Rodionova
EKE. V. Kapp
E. V. Kapp
DDD. V. Duplyakov
D. V. Duplyakov
Acute myocardial infarction (MI), the most severe complication of coronary artery disease, develops in 2-4% of patients with various malignancies. Purpose: to explore the specific properties of ST-segment elevation myocardial infarction (STEMI) course in patients with cancer and its effect on short-term outcome. Materials and methods . We included in this study 45 patients with STEMI and history of cancer hospitalized in the period from 01.01.2015 to 01.01.2017 (group I; 58% men, mean age 69.07±11.60 years). In the comparison group (group II) we selected 90 age and gender matched persons (58% men, mean age 68.16±11.75 years) from patients with STEMI without oncological diseases. Results. There were no differences between groups in main risk factors of cardiovascular diseases, except greater proportion of patients with damage of peripheral arteries in group 1 (22.2% compared with 5.6% in group 2, p=0.025). There were also no differences between groups in clinical characteristics at admission. However values of the following parameters were significantly lower in group I: concentration of hemoglobin (115.56±23.07 vs. 133.70±16.45 g/l in group 2, р<0.001), red blood cell count (3.95±0.66x10 12 /l vs. 5.57±0.72x10 12 /l in group 2, р<0.001), platelets (93±0.97x10 9 /l vs 186±18.3x10 9 /l in group 2, p<0.001), total cholesterol (4.12±2.17 vs. 6.24±2.56 mmol/L in group 2, р<0.001). There were differences in the frequency of use of antiplatelet drugs: at prehospital stage acetylsalicylic acid was given to 48.9% and 77.8% of patients in groups 1 and 2, respectively (p=0.044); clopidogrel and ticagrelor were also significantly more rarely used in group 1. There was no difference in use of thrombolysis and percutaneous coronary interventions (4.4 and 53.3% vs 5.6 and 56.6% in groups 1 and 2, respectively). In group 2 greater portion of patients was given statins (68.9 vs. 77.8%, p=0.021) and angiotensin-converting enzyme inhibitors (55.6 vs. 82.2%, p=0.008). Inhospital mortality was the same in both groups (4.4%). Occurrence of complications (bleeding, pulmonary edema, cardiogenic shock), and frequency of use of intra-aortic balloon counterpulsation, temporary cardiac pacing were similar. However in group 1 greater portion of patients had ventricular tachyarrhythmias (15.6 vs 2.2% in group 2, р=0.007); the presence of cancer was the only independent predictor of their emergence in multiple logistic regression (OR 8.11 [1.11-40.83], p=0.011). Conclusions. Rates of application of myocardial reperfusion in STEMI patients with and without history of cancer were the same. Despite similar hospital mortality revealed peculiarities of STEMI course could affect long-term outcomes. Confirmation of this hypothesis requires planned prospective studies.

14 June 2022 in Research Results in Pharmacology
Verified
Journal Article
Open access
PDF file
MKMarina P. Kiseleva
Marina P. Kiseleva
LBLarisa M. Borisova
Larisa M. Borisova
GSGalina B. Smirnova
Galina B. Smirnova
YBYulia A. Borisova
Yulia A. Borisova
ALAnna Lantsova
Anna Lantsova
MKMarina V. Komarova
Marina V. Komarova
Introduction: The creation of highly effective original anticancer drugs remains an urgent direction of scientific research in tumor therapy. One of the promising groups in this regard is indolocarbazoles and their derivatives, which are capable of initiating various pathways of tumor cell death. The aim of the study was to evaluate an antiproliferative activity of a new, Russian derivative of N-glycoside substituted indolocarbazole 6-amino-12-(α-L-arabinopyranosyl)indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7-dione (LCS-1208) on models of transplantable tumors of mice and on human tumors in Balb/c nude mice. Materials and methods: Indolocarbazole sensitivity to LCS-1208 was assessed on transplantable tumors of mice – lymphatic leukemia L-1210, cervical carcinoma (CC-5), and colon adenocarcinoma (CAC) by five-fold intraperitoneal administration (ip) of the LCS-1208 substance in single doses of 50, 75, 100 mg/kg. Investigation into the effectiveness of the LCS-1208 lyo dosage form was performed on subcutaneous xenografts of human colon cancer SW620 by an in­travenous administration (iv). The antitumor effect was evaluated by the tumor growth inhibition (TGI) and an increase in life span (ILS) of the treated animals as compared with the control ones. Evaluation of specific antitumor activity on xenografts was performed according to the tumor/control (T/C%) criterion (maximum criterion T/C≤42%). Results and discussion: According to the results of the study, the most sensitive to the action of the LCS-1208 sub­stance in the case of an ip administration of a total dose of 375 mg/kg were CAC with TGI=97–62%, p≤0.001 up to 16 days after the treatment, and ILS=36% (criteria for TGI≥70% and ILS≥25%). On xenografts of a human colon cancer SW620, the effectiveness of the LCS-1208 lyo drug dosage form within the range of total doses from 50 to 150 mg/kg in case of iv to Balb/c nude mice was set at T/C = 35–2% (criterion T/C<42%). Conclusion: The presented results suggest possible effectiveness of LCS-1208 in treatment of colon malignant tumors of humans.

1 January 2017 in Siberian journal of oncology
Verified
Journal Article
Open access
PDF file
DDD. Zh. Davydov
D. Zh. Davydov
EMElena Morozova
Elena Morozova
МKМ. V. Komarova
М. V. Komarova
NANatalya Anufrieva
Natalya Anufrieva
ГЗГ. Б. Завильгельский
Г. Б. Завильгельский
VPVadim Pokrovsky
Vadim Pokrovsky
ИСПОЛЬЗОВАНИЕ ПИРИДОКСИНА ДЛЯ ПОВЫШЕНИЯ ПРОТИВООПУХОЛЕВОЙ АКТИВНОСТИ МЕТИОНИН-ГАММАЛИАЗЫ НА МОДЕЛЯХ ПЕРЕВИВАЕМЫХ ОПУХОЛЕЙ МЫШЕЙ